Our data indicate TACC2 expression is increased by DEX in both OE-E6/E7 cells and primary FTE cells, which is consistent with a previous report showing increased expression of TACC2 by DEX in ovarian cancer cells [74]. This evidence concerns the gene TACC2 and ovarian carcinoma.